chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Asthenia, Dizziness, Fatigue, Headache
Clinical narrative: Weakness; Dizziness; Rash; tiredness; headache; muscle pain; joint pain; fever; body aches; nausea; This is a spontaneous report from a contactable consumer or other non hcp. A 44-years-old non pregnant female patient received bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Left arm on 02Mar2021 15:30 (Batch/Lot Number: EN6200, Expiration date: unknown) as 1st DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included fibromyalgia from an unknown date, rubber sensitivity from an unknown date. Concomitant medications included armour thyroid, duloxetine hydrochloride (cymbalta), vitamin d, vitamin c [ascorbic acid]. The patient previously took codeine and experienced drug hypersensitivity. On 04Mar2021 08:00 am the patient experienced weakness, dizziness, rash, tiredness, headache, muscle pain, joint pain, body aches, nausea. Outcome of all the events was not recovered. No follow-up attempts are possible. No further information is expected.
Age: 44.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Myalgia, Nausea, Pain, Pyrexia, Rash
Clinical narrative: Weakness; Dizziness; Rash; tiredness; headache; muscle pain; joint pain; fever; body aches; nausea; This is a spontaneous report from a contactable consumer or other non hcp. A 44-years-old non pregnant female patient received bnt162b2 (BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Left arm on 02Mar2021 15:30 (Batch/Lot Number: EN6200, Expiration date: unknown) as 1st DOSE, SINGLE DOSE for covid-19 immunisation. Medical history included fibromyalgia from an unknown date, rubber sensitivity from an unknown date. Concomitant medications included armour thyroid, duloxetine hydrochloride (cymbalta), vitamin d, vitamin c [ascorbic acid]. The patient previously took codeine and experienced drug hypersensitivity. On 04Mar2021 08:00 am the patient experienced weakness, dizziness, rash, tiredness, headache, muscle pain, joint pain, body aches, nausea. Outcome of all the events was not recovered. No follow-up attempts are possible. No further information is expected.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash, Urticaria
Clinical narrative: Developed pruritic 2 days after immunization followed by diffuse urticaria over her back, chest, and groin. Started on antihistamines and prednisone which improved symptoms. Had no lip swelling, throat swelling, wheezes, cough, or respiratory symptoms.
Age: 70.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Pruritus, Urticaria
Clinical narrative: Developed pruritic 2 days after immunization followed by diffuse urticaria over her back, chest, and groin. Started on antihistamines and prednisone which improved symptoms. Had no lip swelling, throat swelling, wheezes, cough, or respiratory symptoms.
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia, Pain
Clinical narrative: Sour taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old male patient received second dose of BNT162B2(PFIZER- BIONTECH COVID-19 mRNA Vaccine, lot number: E19269/E19266), via an unspecified route of administration on 19Feb2021 at 8:30 AM (at the age of 75-year-old), as a single dose for COVID-19 immunisation. The patient previously received first dose of BNT162B2(PFIZER- BIONTECH COVID-19 mRNA Vaccine, lot number: unknown), via an unspecified route of administration on an unknown date for COVID-19 immunisation. Medical history included allergies to seasonal pollen. Concomitant medications included Plavix and Vytorin. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient has not tested for COVID-19. On an unknown date in Mar2021, the patient experienced sour taste in the mouth. Therapeutic measures were taken as a result of sour taste and included treatment with Tylenol. The clinical outcome of sour taste in mouth was not recovered.   No follow-up attempts are needed. No further information is expected
Age: 75.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dysgeusia
Clinical narrative: Sour taste in mouth; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old male patient received second dose of BNT162B2(PFIZER- BIONTECH COVID-19 mRNA Vaccine, lot number: E19269/E19266), via an unspecified route of administration on 19Feb2021 at 8:30 AM (at the age of 75-year-old), as a single dose for COVID-19 immunisation. The patient previously received first dose of BNT162B2(PFIZER- BIONTECH COVID-19 mRNA Vaccine, lot number: unknown), via an unspecified route of administration on an unknown date for COVID-19 immunisation. Medical history included allergies to seasonal pollen. Concomitant medications included Plavix and Vytorin. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior to the vaccination. Since the vaccination, the patient has not tested for COVID-19. On an unknown date in Mar2021, the patient experienced sour taste in the mouth. Therapeutic measures were taken as a result of sour taste and included treatment with Tylenol. The clinical outcome of sour taste in mouth was not recovered.   No follow-up attempts are needed. No further information is expected
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Injection site hypoaesthesia
Clinical narrative: Numbness on entire arm of injection site; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number- EN6205), via an unspecified route of administration in the left arm on 04Mar2021 at 14:30 (at the age of 46-years-old) as single dose for COVID-19 Immunisation. Medical history included high cholesterol and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive other medications in two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. On 04Mar2021 at 15:00, the patient experienced numbness on entire arm of injection site. No therapeutic measures were taken for the event. The clinical outcome of the event numbness on entire arm of injection site was recovered.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Vaccination site hypoaesthesia
Clinical narrative: Numbness on entire arm of injection site; This is a spontaneous report from a contactable consumer, the patient. A 46-year-old male patient received his first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number- EN6205), via an unspecified route of administration in the left arm on 04Mar2021 at 14:30 (at the age of 46-years-old) as single dose for COVID-19 Immunisation. Medical history included high cholesterol and allergy to penicillin. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive other medications in two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccination. On 04Mar2021 at 15:00, the patient experienced numbness on entire arm of injection site. No therapeutic measures were taken for the event. The clinical outcome of the event numbness on entire arm of injection site was recovered.   No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain, Hepatic pain
Clinical narrative: Extreme liver pain on right side of abdomen from above belly button to below breast; This is spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received her first dose of BNT162B2 (PFIZER BIONTECH COVID 19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration in the left arm on 07Mar2021 at 12:45 (at the age of 62-years-old), as single dose for COVID-19 immunisation. The patient's medical history included gastroesophageal reflux disease (GERD), hiatal hernia, high cholesterol, mitral valve repair and osteoarthritis. The patient had allergy to Flonase, cipro, sulfa drugs, Synvisc, naproxen sodium, milk, wheat, eggs and peanuts. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included PRILOSEC, gabapentin (MANUFACTURER UNKNOWN) and LEVOXYL, all for unknown indications and unknown if ongoing. The patient did not receive any vaccines within four weeks prior to the COVID vaccine. On 09Mar2021, the patient experienced extreme liver pain on right side of abdomen from above belly button to below breast. The clinical outcome of the event extreme liver pain on right side of abdomen from above belly button to below breast was unknown. No follow-up attempts are needed. No further information is expected.
Age: 62.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hepatic pain
Clinical narrative: Extreme liver pain on right side of abdomen from above belly button to below breast; This is spontaneous report from a contactable consumer, the patient. A 62-year-old non-pregnant female patient received her first dose of BNT162B2 (PFIZER BIONTECH COVID 19 mRNA VACCINE; Lot number: EN6205), via an unspecified route of administration in the left arm on 07Mar2021 at 12:45 (at the age of 62-years-old), as single dose for COVID-19 immunisation. The patient's medical history included gastroesophageal reflux disease (GERD), hiatal hernia, high cholesterol, mitral valve repair and osteoarthritis. The patient had allergy to Flonase, cipro, sulfa drugs, Synvisc, naproxen sodium, milk, wheat, eggs and peanuts. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included PRILOSEC, gabapentin (MANUFACTURER UNKNOWN) and LEVOXYL, all for unknown indications and unknown if ongoing. The patient did not receive any vaccines within four weeks prior to the COVID vaccine. On 09Mar2021, the patient experienced extreme liver pain on right side of abdomen from above belly button to below breast. The clinical outcome of the event extreme liver pain on right side of abdomen from above belly button to below breast was unknown. No follow-up attempts are needed. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Feeling abnormal, Headache, Impaired driving ability
Clinical narrative: very spacey, woozy; head felt very achey; Fatigue; This is a spontaneous report from a contactable Consumer, the Patient. A 58 year old female non-pregnant patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number; unknown) via an unspecified route of administration on 16Mar2021 at 19:00 PM (at the age of 58 years old), as a Single dose for COVID-19 Immunisation. The Patient medical history include Hashimotos, Chronic Functional Abdominal pain, insomnia and back pain from unknown date. The patient was sensitive to sulfa, gluten, dairy and soy. Prior to vaccination, patient was not diagnosed with COVID-19, Since the vaccination, patient was not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. Concomitant medications include Synthroid for unknown indication from unknown date. The patient experienced very spacey, woozy and my head felt very achey and Fatigue on 17Mar2021. Patient took Tylenol. It helps some to the patient. The patient did not receive treatment for the reported event. The clinical outcome of the dizzy, headache and fatigue was not recovered. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 58.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Headache
Clinical narrative: very spacey, woozy; head felt very achey; Fatigue; This is a spontaneous report from a contactable Consumer, the Patient. A 58 year old female non-pregnant patient received BNT162B2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Lot number; unknown) via an unspecified route of administration on 16Mar2021 at 19:00 PM (at the age of 58 years old), as a Single dose for COVID-19 Immunisation. The Patient medical history include Hashimotos, Chronic Functional Abdominal pain, insomnia and back pain from unknown date. The patient was sensitive to sulfa, gluten, dairy and soy. Prior to vaccination, patient was not diagnosed with COVID-19, Since the vaccination, patient was not been tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccination. Concomitant medications include Synthroid for unknown indication from unknown date. The patient experienced very spacey, woozy and my head felt very achey and Fatigue on 17Mar2021. Patient took Tylenol. It helps some to the patient. The patient did not receive treatment for the reported event. The clinical outcome of the dizzy, headache and fatigue was not recovered. Information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Injection site pain, Myalgia
Clinical narrative: Headache; Chills; Muscle aches; Tiredness; Sore at injection site; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 61-year-old) as a single dose for COVID-19 Immunisation. The patients medical history included high BP and diabetes Type 2. The patients concomitant medications included atenolol (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN) and metformin (MANUFACTURER UNKNOWN) for an unknown indication from unknown date. The patient did not have any allergies to medications, food or other products. The patient did not receive any other vaccine within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced Headache, chills, muscle aches, tired and sore at injection site on 17Mar2021 at 15.00. The patient did not receive any treatment for the adverse events. At the time of report, the clinical outcome of the events Headache, chills, muscle aches, tired and sore at injection site were recovering.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Headache, Myalgia, Vaccination site pain
Clinical narrative: Headache; Chills; Muscle aches; Tiredness; Sore at injection site; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 13:00 (at the age of 61-year-old) as a single dose for COVID-19 Immunisation. The patients medical history included high BP and diabetes Type 2. The patients concomitant medications included atenolol (MANUFACTURER UNKNOWN), spironolactone (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN) and metformin (MANUFACTURER UNKNOWN) for an unknown indication from unknown date. The patient did not have any allergies to medications, food or other products. The patient did not receive any other vaccine within four weeks prior to the vaccination. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient experienced Headache, chills, muscle aches, tired and sore at injection site on 17Mar2021 at 15.00. The patient did not receive any treatment for the adverse events. At the time of report, the clinical outcome of the events Headache, chills, muscle aches, tired and sore at injection site were recovering.   Information about lot/batch number cannot be obtained. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Headache, Nausea
Clinical narrative: Fatigue; Mild dizziness; Mlid nausea; Intermittent headache; Body aches; intermittent neck pain, especially on same side as injection site (Left Arm); This is a spontaneous report received from a contactable consumer, the patient. A 53-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in left arm on 17Mar2021 at 13:30 hours (at the age of 53-years) as a single dose for COVID-19 immunisation. The patients medical history included aortic dissection/aneurysm in 2016, hypertension, anxiety/depression. The patient was allergic to latex, artificial sweeteners and artificial cinnamon flavouring agent. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patients concomitant medications included blood pressure medications (unspecified) and statins (unspecified). The patient received these medications within 2 weeks of vaccination. On 18Mar2021 at 11:00 hours, the patient experienced fatigue, mild dizziness, mild nausea, intermittent headache, intermittent neck pain especially on same side as injection site and body aches (other than injection site). The patient did not receive any treatments for these events. The clinical outcome of the events fatigue, mild dizziness, mild nausea, intermittent headache, intermittent neck pain especially on same side as injection site and body aches (other than injection site) was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Fatigue, Headache, Nausea, Neck pain
Clinical narrative: Fatigue; Mild dizziness; Mlid nausea; Intermittent headache; Body aches; intermittent neck pain, especially on same side as injection site (Left Arm); This is a spontaneous report received from a contactable consumer, the patient. A 53-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in left arm on 17Mar2021 at 13:30 hours (at the age of 53-years) as a single dose for COVID-19 immunisation. The patients medical history included aortic dissection/aneurysm in 2016, hypertension, anxiety/depression. The patient was allergic to latex, artificial sweeteners and artificial cinnamon flavouring agent. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patients concomitant medications included blood pressure medications (unspecified) and statins (unspecified). The patient received these medications within 2 weeks of vaccination. On 18Mar2021 at 11:00 hours, the patient experienced fatigue, mild dizziness, mild nausea, intermittent headache, intermittent neck pain especially on same side as injection site and body aches (other than injection site). The patient did not receive any treatments for these events. The clinical outcome of the events fatigue, mild dizziness, mild nausea, intermittent headache, intermittent neck pain especially on same side as injection site and body aches (other than injection site) was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 53.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Pain
Clinical narrative: Fatigue; Mild dizziness; Mlid nausea; Intermittent headache; Body aches; intermittent neck pain, especially on same side as injection site (Left Arm); This is a spontaneous report received from a contactable consumer, the patient. A 53-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: ER2613) via an unspecified route of administration in left arm on 17Mar2021 at 13:30 hours (at the age of 53-years) as a single dose for COVID-19 immunisation. The patients medical history included aortic dissection/aneurysm in 2016, hypertension, anxiety/depression. The patient was allergic to latex, artificial sweeteners and artificial cinnamon flavouring agent. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient was not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patients concomitant medications included blood pressure medications (unspecified) and statins (unspecified). The patient received these medications within 2 weeks of vaccination. On 18Mar2021 at 11:00 hours, the patient experienced fatigue, mild dizziness, mild nausea, intermittent headache, intermittent neck pain especially on same side as injection site and body aches (other than injection site). The patient did not receive any treatments for these events. The clinical outcome of the events fatigue, mild dizziness, mild nausea, intermittent headache, intermittent neck pain especially on same side as injection site and body aches (other than injection site) was resolving.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Hives on upper and lower bodies; Rash on upper and lower bodies; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration in left arm on 17Mar2021 at 09:30 (at the age of 36-years-old) as single dose of COVID-19 immunisation. Medical history was not provided. The patient did not have allergy to food, medications or other products. Concomitant medication included Augmentin for unknown indication and is unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent lab test on 17Mar2021 which included nasal swab (PCR) and the result was found to be negative. Since vaccination, the patient was not tested positive with COVID-19. On 18Mar2021 at 05:30, the patient experienced rash and hives on upper and lower bodies. It was reported that the patient did not experience shortness of breath or anaphylactic symptoms. Therapeutic measures were taken as a result of rash and hives on upper and lower bodies and included treatment with Benadryl and steroids (MANUFACTURER UNKNOWN). It was reported that hives came back at 12:00-14:00 on the same day, so the patient took double dose of Benadryl. The clinical outcome of events rash and hives on upper and lower bodies were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 36.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Polymerase chain reaction, Rash, Urticaria
Clinical narrative: Hives on upper and lower bodies; Rash on upper and lower bodies; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6200) via an unspecified route of administration in left arm on 17Mar2021 at 09:30 (at the age of 36-years-old) as single dose of COVID-19 immunisation. Medical history was not provided. The patient did not have allergy to food, medications or other products. Concomitant medication included Augmentin for unknown indication and is unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient underwent lab test on 17Mar2021 which included nasal swab (PCR) and the result was found to be negative. Since vaccination, the patient was not tested positive with COVID-19. On 18Mar2021 at 05:30, the patient experienced rash and hives on upper and lower bodies. It was reported that the patient did not experience shortness of breath or anaphylactic symptoms. Therapeutic measures were taken as a result of rash and hives on upper and lower bodies and included treatment with Benadryl and steroids (MANUFACTURER UNKNOWN). It was reported that hives came back at 12:00-14:00 on the same day, so the patient took double dose of Benadryl. The clinical outcome of events rash and hives on upper and lower bodies were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Arthralgia, Back pain, Gait disturbance, Musculoskeletal stiffness, Pain
Clinical narrative: Chills; cough; \This is a spontaneous report from a contactable Nurse (patient). A 67-year-old female non-pregnant patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 19Feb2021 (at the age of 67-year-old) (Batch/Lot Number: EN6201) as 2ND DOSE SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (BNT162B2) via an unspecified route of administration, administered in Arm Right on 28Jan2021 at 01:00 PM (at the age of 67-year-old) (Batch/Lot number: EL9264) for covid-19 immunization.The patient previously received Demerol and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19. Since the vaccination, the patient not been tested with covid-19. On 01Mar2021 at 12:00 AM the patient experienced chills and cough. It was reported that not treatment was taken for the events. The outcome of the events were reported as not recovered  No follow up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough
Clinical narrative: Chills; cough; \This is a spontaneous report from a contactable Nurse (patient). A 67-year-old female non-pregnant patient received bnt162b2 (BNT162B2), dose 2 via an unspecified route of administration, administered in Arm Right on 19Feb2021 (at the age of 67-year-old) (Batch/Lot Number: EN6201) as 2ND DOSE SINGLE DOSE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient previously took first dose of bnt162b2 (BNT162B2) via an unspecified route of administration, administered in Arm Right on 28Jan2021 at 01:00 PM (at the age of 67-year-old) (Batch/Lot number: EL9264) for covid-19 immunization.The patient previously received Demerol and experienced allergy. The patient did not receive any other vaccines within 4 weeks prior to the covid vaccine. Prior to vaccination, the patient was not diagnosed with covid-19. Since the vaccination, the patient not been tested with covid-19. On 01Mar2021 at 12:00 AM the patient experienced chills and cough. It was reported that not treatment was taken for the events. The outcome of the events were reported as not recovered  No follow up attempts are possible. No further information is expected.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Cough, Eye disorder, Fatigue, Malaise
Clinical narrative: Soreness at injection spot; chills; pains and achy; muscle spasm in right lower quadrant underneath rib cage; fatigue; sleeping; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 67-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown, Expiration Date: unknown) via an unspecified route of administration, administered in left arm on 05Mar2021 at 16:15 pm (age at vaccination was 67 years) as 1ST DOSE, SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had known allergy to bee stings. On 06Mar2021 at 00:00 am, the patient experienced soreness at injection spot, chills, pains and achy, muscle spasm in right lower quadrant underneath rib cage, fatigue and sleeping. The facility where the most recent COVID-19 vaccine was administered was other (Residential Community). The patient did not receive any other medications in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse event. The outcome of events was resolving.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Mobility decreased, Pain, Parosmia, Pyrexia, Respiration abnormal
Clinical narrative: Soreness at injection spot; chills; pains and achy; muscle spasm in right lower quadrant underneath rib cage; fatigue; sleeping; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 67-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown, Expiration Date: unknown) via an unspecified route of administration, administered in left arm on 05Mar2021 at 16:15 pm (age at vaccination was 67 years) as 1ST DOSE, SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had known allergy to bee stings. On 06Mar2021 at 00:00 am, the patient experienced soreness at injection spot, chills, pains and achy, muscle spasm in right lower quadrant underneath rib cage, fatigue and sleeping. The facility where the most recent COVID-19 vaccine was administered was other (Residential Community). The patient did not receive any other medications in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse event. The outcome of events was resolving.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Taste disorder
Clinical narrative: Soreness at injection spot; chills; pains and achy; muscle spasm in right lower quadrant underneath rib cage; fatigue; sleeping; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 67-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown, Expiration Date: unknown) via an unspecified route of administration, administered in left arm on 05Mar2021 at 16:15 pm (age at vaccination was 67 years) as 1ST DOSE, SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had known allergy to bee stings. On 06Mar2021 at 00:00 am, the patient experienced soreness at injection spot, chills, pains and achy, muscle spasm in right lower quadrant underneath rib cage, fatigue and sleeping. The facility where the most recent COVID-19 vaccine was administered was other (Residential Community). The patient did not receive any other medications in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse event. The outcome of events was resolving.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Fatigue, Muscle spasms, Pain, Sleep disorder
Clinical narrative: Soreness at injection spot; chills; pains and achy; muscle spasm in right lower quadrant underneath rib cage; fatigue; sleeping; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 67-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown, Expiration Date: unknown) via an unspecified route of administration, administered in left arm on 05Mar2021 at 16:15 pm (age at vaccination was 67 years) as 1ST DOSE, SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had known allergy to bee stings. On 06Mar2021 at 00:00 am, the patient experienced soreness at injection spot, chills, pains and achy, muscle spasm in right lower quadrant underneath rib cage, fatigue and sleeping. The facility where the most recent COVID-19 vaccine was administered was other (Residential Community). The patient did not receive any other medications in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse event. The outcome of events was resolving.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 67.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Vaccination site pain
Clinical narrative: Soreness at injection spot; chills; pains and achy; muscle spasm in right lower quadrant underneath rib cage; fatigue; sleeping; This is a spontaneous report from a contactable consumer (patient) reported for herself. A 67-years-old female patient (patient was not pregnant at the time of vaccination) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: unknown, Expiration Date: unknown) via an unspecified route of administration, administered in left arm on 05Mar2021 at 16:15 pm (age at vaccination was 67 years) as 1ST DOSE, SINGLE DOSE for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had known allergy to bee stings. On 06Mar2021 at 00:00 am, the patient experienced soreness at injection spot, chills, pains and achy, muscle spasm in right lower quadrant underneath rib cage, fatigue and sleeping. The facility where the most recent COVID-19 vaccine was administered was other (Residential Community). The patient did not receive any other medications in two weeks. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse event. The outcome of events was resolving.  No follow-up attempts are possible; information about lot/batch number cannot been obtained.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia
Clinical narrative: It made my arm feel numb; tightness moved to my neck and lower shoulder; This is a spontaneous report received from a contactable consumer, the patient. A 46-year-old non-pregnant-female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6208 or EW6208) via an unspecified route of administration in her left arm on 12March2021 at 13:45 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included only seasonal allergies and had no other medical history. The patient had no Allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. She did not receive any other medications within 02 weeks of vaccination. On 12Mar2021 at 13:45, the patient could feel the vaccine moving down in her arm which made her to felt numbness in the arm and it came to her wrist then travelled back up to her underside of arm into the shoulder. Then, the numbness and tightness moved to her neck and lower shoulder. It eventually made its way to her chin and bra strap area. At that point, she took a Benadryl as a treatment for of the events. Within 15 to 20 minutes after having the Benadryl, her numbness was stopped. The clinical outcome of the event numbness in arm was resolved on 12Mar2021, however the outcome of the event tightness moved to her neck and lower shoulder was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 46.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hypoaesthesia, Muscle tightness
Clinical narrative: It made my arm feel numb; tightness moved to my neck and lower shoulder; This is a spontaneous report received from a contactable consumer, the patient. A 46-year-old non-pregnant-female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EN6208 or EW6208) via an unspecified route of administration in her left arm on 12March2021 at 13:45 (at the age of 46-year-old) as a single dose for COVID-19 immunisation. Medical history included only seasonal allergies and had no other medical history. The patient had no Allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID-19 vaccine. She did not receive any other medications within 02 weeks of vaccination. On 12Mar2021 at 13:45, the patient could feel the vaccine moving down in her arm which made her to felt numbness in the arm and it came to her wrist then travelled back up to her underside of arm into the shoulder. Then, the numbness and tightness moved to her neck and lower shoulder. It eventually made its way to her chin and bra strap area. At that point, she took a Benadryl as a treatment for of the events. Within 15 to 20 minutes after having the Benadryl, her numbness was stopped. The clinical outcome of the event numbness in arm was resolved on 12Mar2021, however the outcome of the event tightness moved to her neck and lower shoulder was unknown.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Dizziness, Erythema, Feeling hot, Flushing, Nausea
Clinical narrative: Feeling funny; face, hands, arms redness; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old, non-pregnant female patient received first dose of BNT162B2 (Pfizer BioNTech Covid 19 mRNA Vaccine; lot number ER2613) via an unspecified route of administration on arm left as a single dose for COVID-19 immunisation on 18Mar2021 at 16:00 hours. The patient's medical history reported of diabetes 2, transthyretin-mediated amyloidosis and irritable bowel syndrome. The patient had allergies to sulfa, PHENERGAN, lisinopril, codeine, MINOCIN. The concomitant medications included BASAGLAR, CELEXA, losartan (MANUFACTURER UNKNOWN), NOVOLOG and simvastatin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. On 18Mar2021 at 16:15, approximately 15 minutes after injection the patient began to feel funny. On same day, the patient noticed she was turning red. The patient was taken to medication area for evaluation. The patient feeling off got progressively worse as did the redness and the patient also had redness on face, hands and arms. 50 mg of BENADRYL was administered via intramuscular route. After about 30 minutes reaction had subsided and it took about 3.5 hours before she felt herself again. The clinical outcome of the events feeling funny, redness on face, hands, arms was recovered on 18Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 59.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Erythema, Feeling abnormal
Clinical narrative: Feeling funny; face, hands, arms redness; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old, non-pregnant female patient received first dose of BNT162B2 (Pfizer BioNTech Covid 19 mRNA Vaccine; lot number ER2613) via an unspecified route of administration on arm left as a single dose for COVID-19 immunisation on 18Mar2021 at 16:00 hours. The patient's medical history reported of diabetes 2, transthyretin-mediated amyloidosis and irritable bowel syndrome. The patient had allergies to sulfa, PHENERGAN, lisinopril, codeine, MINOCIN. The concomitant medications included BASAGLAR, CELEXA, losartan (MANUFACTURER UNKNOWN), NOVOLOG and simvastatin (MANUFACTURER UNKNOWN). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination the patient has not been tested for COVID-19. On 18Mar2021 at 16:15, approximately 15 minutes after injection the patient began to feel funny. On same day, the patient noticed she was turning red. The patient was taken to medication area for evaluation. The patient feeling off got progressively worse as did the redness and the patient also had redness on face, hands and arms. 50 mg of BENADRYL was administered via intramuscular route. After about 30 minutes reaction had subsided and it took about 3.5 hours before she felt herself again. The clinical outcome of the events feeling funny, redness on face, hands, arms was recovered on 18Mar2021.   No follow-up attempts are needed. No further information is expected.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Impaired work ability, Tinnitus
Clinical narrative: ABOUT 4 HOURS AFTER 2ND DOSE PATIEN STATES TINNITIS ABOVE/TOP OF HEAD AND BRAIN FOG.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Acoustic stimulation tests, Antinuclear antibody, Blood immunoglobulin G, Feeling abnormal, Full blood count
Clinical narrative: ABOUT 4 HOURS AFTER 2ND DOSE PATIEN STATES TINNITIS ABOVE/TOP OF HEAD AND BRAIN FOG.
Age: 63.0
Sex: M
Vaccine: COVID19, COVID19
Symptoms: Metabolic function test, SARS-CoV-2 test, Tinnitus
Clinical narrative: ABOUT 4 HOURS AFTER 2ND DOSE PATIEN STATES TINNITIS ABOVE/TOP OF HEAD AND BRAIN FOG.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Full blood count abnormal, Full blood count normal, Peripheral swelling, Rash
Clinical narrative: Red rash and blotches on both upper arms; Red rash and blotches on both upper arms; This is a spontaneous report received from a contactable consumer, the patient. A 78-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6208) via an unspecified route of administration on the right arm on 17Mar2021 at 14:00 (at the age of 78-year-old), as single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to Zithromax Z- Pac antibiotics. Concomitant medication include PROLIA . The patient received PROLIA  vaccination within 4 weeks of COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced red rash and blotches on both upper arms on 18Mar2021 at 19:00 hours. The patient received treatment for the reported events with benadryl. The clinical outcome of the event red rash and red blotches were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 78.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Rash erythematous, Rash macular
Clinical narrative: Red rash and blotches on both upper arms; Red rash and blotches on both upper arms; This is a spontaneous report received from a contactable consumer, the patient. A 78-year-old non pregnant female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot no: EN6208) via an unspecified route of administration on the right arm on 17Mar2021 at 14:00 (at the age of 78-year-old), as single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to Zithromax Z- Pac antibiotics. Concomitant medication include PROLIA . The patient received PROLIA  vaccination within 4 weeks of COVID-19 vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient experienced red rash and blotches on both upper arms on 18Mar2021 at 19:00 hours. The patient received treatment for the reported events with benadryl. The clinical outcome of the event red rash and red blotches were not resolved at the time of this report.   No follow-up attempts are needed. No further information is expected.
Age: 40.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Capillary fragility, Nausea, Vomiting
Clinical narrative: violently vomiting; nauseous; losing weight; my labs are a mess; losing hair; short of breath; dizzy; I have never felt so awful for so long.; can barely eat; This is a spontaneous report from a contactable consumer (patient). A 40-year-old female patient received bnt162b2 (BNT162B2), via an unspecified route of administration, administered in Arm Right on 16Mar2021 09:00 (Batch/Lot number was not reported) at single dose for COVID-19 immunization.  Medical history included Lupus, Postural orthostatic tachycardia syndrome (POTS), depression, Axial Spondyloarthritis, Degenerative Disc Disease. Concomitant medications included unspecified medications, the patient was on quite a few, she didn't fit. The patient's known allergies Ambient, augmentin, doxycycline (not anaphylaxis). No other vaccine in four weeks. Vaccine 16Mar2021, day after she started violently vomiting. She had vomited al-most every day since, she was nauseous 24/7, she can barely eat so she was losing weight and her labs were a mess, she had to get IV Iron yesterday (19May2021), and she had a ton other GI tests coming up. She was losing hair, I'm getting barely any nutrients. She was now short of breath and dizzy too. She had never felt so awful for so long. Adverse event start date was 17Mar2021. Adverse event start time was 07:00 AM. Adverse events resulted in Doctor or other healthcare professional office/clinic visit. The patient received treatment for the events included intravenous Iron, tried different medicine, lots of appts. No covid prior vaccination. No covid tested post vaccination. The adverse events did not result in death, did not cause/prolong hospitalization, was not life threatening, disabling/incapacitating, congenital anomaly/birth defect. All events considered as serious due to being medically significant. The outcome of the events was not recovered.  Information on the lot/batch number has been requested.